Christopher Fleury
Plastic and Reconstructive Surgery · Chevy Chase, MDNPI 1871026278
Payments from drug & device makers
What this record shows
This record is dominated by grants: $9,990 of the $10,275 with a category attached, or 97.2%. Arthrex accounts for 97.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $9,990 and has fallen 98.2% since, to $183 in 2025. Among plastic and reconstructive surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $790.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- AbbVie$98
- Integra Lifesciences Corporation$80
- Axogen$35
- Johnson & Johnson$32
- Pacira Pharmaceuticals Incorporated$22
- plus $18 from 1 others
What the payments were for
- Grants$9,99097%
- Food & beverage$2853%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $9,990 |
| AbbVie | 4 | $98 |
| Integra Lifesciences Corporation | 4 | $80 |
| Axogen | 1 | $35 |
| Johnson & Johnson | 1 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Biocircuit Technologies Inc | 1 | $18 |
How this compares
$10,275 in reported general payments places this provider in the 90th percentile of 55 plastic and reconstructive surgery providers in Maryland.
See all plastic and reconstructive surgery providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Chevy Chase
- Arjun KanuriChevy Chase$6K
- Eric KhairallaChevy Chase$6K
- Stephen KayChevy Chase$662
- Behnaz FayaziChevy Chase$639
- David KungChevy Chase$406
- Monte HarrisChevy Chase$210
- Kristen BroderickBaltimore$40K
- Deasia JacobFrederick$24K
- Branko BojovicBaltimore$19K
- Gabriel del CorralWestminster$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.